Dimerix Ltd Cash Flow Conversion Efficiency

Latest as of June 2025: 3.087x

Dimerix Ltd cash flow conversion efficiency. Based on the latest financial reports, Dimerix Ltd (DXB) has a cash flow conversion efficiency ratio of 3.087x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$41.30 Million ≈ $29.22 Million USD) by net assets (AU$13.38 Million ≈ $9.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Dimerix Ltd (1992–2025)

Cash flow conversion efficiency of Dimerix Ltd from 1992 to 2025. This chart illustrates how Dimerix Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Dimerix Ltd (DXB) stock price for real-time trading data and today's change.

Dimerix Ltd Cash Flow Conversion Ratio Explained

Dimerix Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Dimerix Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Dimerix Ltd ranked by their cash flow conversion efficiency. Also see DXB company net worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Sahacogen (Chonburi) Public Company Limited
BK:SCG
0.017x
Axis Corporation
TWO:6292
0.190x
Mahachai Hospital Public Company Limited
BK:M-CHAI
0.165x
Braemar Hotel & Resorts Inc
NYSE:BHR
0.044x
Bank Pembangunan Timur Tbk
JK:BJTM
0.111x
Zeder Investments Ltd
JSE:ZED
0.180x
Suraj Estate Developers Ltd.
NSE:SURAJEST
0.007x
Foncière Volta
PA:SPEL
0.011x

Annual Cash Flow Conversion Efficiency for Dimerix Ltd (1992–2025)

The table below shows the annual cash flow conversion efficiency of Dimerix Ltd from 1992 to 2025. Review how much free cash does Dimerix Ltd generate to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$13.38 Million
≈ $9.47 Million
AU$39.05 Million
≈ $27.63 Million
2.919x +857.87%
2024-06-30 AU$18.19 Million
≈ $12.87 Million
AU$-7.00 Million
≈ $-4.96 Million
-0.385x +81.96%
2023-06-30 AU$5.96 Million
≈ $4.22 Million
AU$-12.73 Million
≈ $-9.01 Million
-2.135x -129.17%
2022-06-30 AU$14.42 Million
≈ $10.20 Million
AU$-13.44 Million
≈ $-9.51 Million
-0.932x +78.83%
2021-06-30 AU$1.47 Million
≈ $1.04 Million
AU$-6.46 Million
≈ $-4.57 Million
-4.401x -623.25%
2020-06-30 AU$7.76 Million
≈ $5.49 Million
AU$-4.72 Million
≈ $-3.34 Million
-0.608x +7.03%
2019-06-30 AU$4.20 Million
≈ $2.97 Million
AU$-2.75 Million
≈ $-1.95 Million
-0.655x -39.16%
2018-06-30 AU$6.86 Million
≈ $4.85 Million
AU$-3.23 Million
≈ $-2.28 Million
-0.470x +33.66%
2017-06-30 AU$2.63 Million
≈ $1.86 Million
AU$-1.86 Million
≈ $-1.32 Million
-0.709x -15.29%
2016-06-30 AU$2.24 Million
≈ $1.59 Million
AU$-1.38 Million
≈ $-975.82K
-0.615x -205.76%
2015-06-30 AU$2.78 Million
≈ $1.96 Million
AU$-558.55K
≈ $-395.21K
-0.201x +58.31%
2014-06-30 AU$1.18 Million
≈ $834.33K
AU$-568.88K
≈ $-402.52K
-0.482x +97.30%
2014-04-30 AU$31.22K
≈ $22.09K
AU$-558.55K
≈ $-395.21K
-17.893x -9885.60%
2013-06-30 AU$1.71 Million
≈ $1.21 Million
AU$-305.90K
≈ $-216.44K
-0.179x +9.01%
2012-06-30 AU$1.18 Million
≈ $834.76K
AU$-232.33K
≈ $-164.39K
-0.197x +5.57%
2011-06-30 AU$1.57 Million
≈ $1.11 Million
AU$-326.54K
≈ $-231.04K
-0.209x +12.93%
2010-06-30 AU$1.56 Million
≈ $1.10 Million
AU$-373.67K
≈ $-264.39K
-0.240x +95.32%
2009-06-30 AU$341.98K
≈ $241.97K
AU$-1.75 Million
≈ $-1.24 Million
-5.113x -114.66%
2008-06-30 AU$1.01 Million
≈ $713.34K
AU$-2.40 Million
≈ $-1.70 Million
-2.382x -103.42%
2007-06-30 AU$1.41 Million
≈ $1.00 Million
AU$-1.66 Million
≈ $-1.17 Million
-1.171x -56.68%
2006-06-30 AU$2.69 Million
≈ $1.91 Million
AU$-2.01 Million
≈ $-1.42 Million
-0.747x -405.76%
2005-06-30 AU$10.28 Million
≈ $7.27 Million
AU$-1.52 Million
≈ $-1.07 Million
-0.148x -102.79%
2004-06-30 AU$-170.38K
≈ $-120.55K
AU$-902.37K
≈ $-638.48K
5.296x +422.93%
2003-06-30 AU$-565.02K
≈ $-399.79K
AU$-572.26K
≈ $-404.91K
1.013x +147.45%
2002-06-30 AU$282.89K
≈ $200.16K
AU$-603.82K
≈ $-427.24K
-2.135x -1434.07%
2001-06-30 AU$640.43K
≈ $453.14K
AU$102.47K
≈ $72.50K
0.160x +74.25%
2000-06-30 AU$5.24 Million
≈ $3.71 Million
AU$481.16K
≈ $340.45K
0.092x -48.60%
1999-06-30 AU$5.77 Million
≈ $4.08 Million
AU$1.03 Million
≈ $729.49K
0.179x +303.76%
1997-06-30 AU$1.96 Million
≈ $1.39 Million
AU$-171.60K
≈ $-121.42K
-0.088x -29.69%
1996-06-30 AU$1.85 Million
≈ $1.31 Million
AU$-125.03K
≈ $-88.47K
-0.068x +5.26%
1995-06-30 AU$1.72 Million
≈ $1.22 Million
AU$-123.00K
≈ $-87.03K
-0.071x -16.09%
1994-06-30 AU$1.74 Million
≈ $1.23 Million
AU$-107.00K
≈ $-75.71K
-0.061x -147.59%
1993-06-30 AU$1.41 Million
≈ $997.66K
AU$-35.00K
≈ $-24.76K
-0.025x -299.35%
1992-06-30 AU$1.04 Million
≈ $738.70K
AU$13.00K
≈ $9.20K
0.012x --

About Dimerix Ltd

AU:DXB Australia Biotechnology
Market Cap
$89.21 Million
AU$126.08 Million AUD
Market Cap Rank
#19448 Global
#623 in Australia
Share Price
AU$0.21
Change (1 day)
-2.33%
52-Week Range
AU$0.17 - AU$0.63
All Time High
AU$0.77
About

Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia. It develops DMX-200 for the treatment of focal segmental glomerulosclerosis disease, diabetic kidney disease, and ARDS associated with COVID-19; and DMX-700 for orphan respiratory/renal disease, as well as proprietary Receptor-HIT assay technology. The company is… Read more